Last updated: 24th Aug 2011 at 08:50am
Sales at breast implant manufacturer Nagor have soared over the past six months after a French implant product was taken off the market. The Ashby-de-la-Zouch-based company told Insider that its 2011 revenues have increased by more than 60 per cent while staff numbers have reached more than 100 for the first time.
Nagor said sales were given a boost over the last year after implant manufacturer Poly Implant Prosthese (PIP) was closed down by French authorities. The company, which ceased operating in 2010, was accused of using a non-approved silicone gel for almost ten years.
According to Nagor, which claims to be the UK’s only silicone breast implant manufacturer, tens of thousands of PIP breast implants sold in the UK were filled with a substance said to be meant for mattresses.
Despite test results showing no toxic effect from the gel in the French implants, the operation was shut down until further tests could be carried out to determine the product’s safety.
In the last six months, Nagor said sales had increased by 63 per cent compared to last year. The company’s staff numbers have grown by nearly 12 per cent over the past year, with new recruits having been added to its Ashby headquarters and its second base in Cumbernauld, Scotland.
From 2009 to 2010, Nagor said the number of implants sold jumped from 43,121 to 52,985 – a rise of 22 per cent. Sales in 2011 currently stand at 41,273 – a leap of 63 per cent compared to this same time last year, when sales were only 25,268.
Nagor’s UK sales manager Douglas Black said: "Recent statistics confirm that breast augmentation continues to be the most popular form of aesthetic plastic surgery and an estimated 25,000 women underwent the procedure in Britain alone last year. It is becoming clear that since the recent PIP implant scandal the UK public are becoming more cautious and educated about their options."
Nagor is currently sponsoring a multicentre Prospective Post Market Clinical Study to collect data on the long term safety and performance of its gel-filled breast implants. The company also provides its products to the NHS for breast reconstruction patients